Skip to main content
. 2015 Dec 21;78(4):649–656. doi: 10.1292/jvms.15-0625

Table 3. Immunohistochemical staining intensity.

No. c-kit VEGFR-2 PDGFR-2 PI3K Akt m-TOR MEK1 MEK2 ERK
HSA (%) a) 1 4.0 52.0 6.0 25.1 4.8 11.0 9.7 42.2 1.9
2 3.8 35.1 6.1 22.4 4.9 13.3 22.4 36.8 4.0
3 1.1 51.2 3.6 27.1 3.7 15.0 19.4 49.2 5.0
4 20.9 34.7 35.9 28.5 4.7 11.6 11.4 33.7 28.3
5 2.3 12.4 2.2 20.4 2.6 4.6 6.4 19.4 1.9
6 2.2 31.2 36.5 32.9 1.9 6.8 27.5 48.4 2.4
7 1.6 35.5 2.7 22.5 2.4 15.9 20.1 32.1 2.0
8 17.5 47.3 25.8 40.5 4.8 7.0 8.2 59.3 20.2
9 2.2 36.5 24.5 26.3 1.5 17.5 12.3 35.0 1.7
10 10.8 37.4 4.1 37.2 2.7 11.7 16.8 32.7 2.1
Average b) 6.6 37.3 14.8 28.3 3.4 11.4 15.4 38.9 7.0
Control 11 6.0 7.3 5.0 7.7 6.6 5.9 6.5 7.2 4.6
(%) 12 4.9 8.5 6.1 6.4 4.7 3.3 3.9 7.1 5.7
Average 5.4 7.9 5.5 7.1 5.7 4.6 5.2 7.2 5.1

a) %, percentage of the totals of positive area per the totals of all area among three fields of vision chosen at random; b) Average, average of each percentage.